Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Smart Olfaction App to Reduce Relapse

NCT: NCT07007195 · RECRUITING

NCT IDNCT07007195
StatusRECRUITING
Start Date2026-04-22
Completion2027-08-31

Brief Summary

The proposed project aims to refine and test a novel biobehavioral smoking cessation intervention that integrates the strategic application of olfactory stimulation to reduce cigarette craving with an established smartphone-based smoking cessation application. The specific aims of this study are: (1) refine the design and methodology of our olfactory stimulation delivery system (OSDS) and (2) compare, in a pilot randomized controlled trial (RCT), the effects of a smartphone based app for smoking cessation (Smart-T) with and without the OSDS on smoking cessation outcomes.

Frequently Asked Questions

What is Smart Olfaction App to Reduce Relapse?

Smart Olfaction App to Reduce Relapse is a clinical trial registered under NCT07007195. Current status: RECRUITING.

What is the status of NCT07007195?

The current status of NCT07007195 (Smart Olfaction App to Reduce Relapse) is: RECRUITING.

When did Smart Olfaction App to Reduce Relapse start?

Smart Olfaction App to Reduce Relapse started on 2026-04-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.